Viking Therapeutics (VKTX)'s 30-day implied volatility (IV30) was 62.6% at the close on November 17, 2026, up from 60.7% the day before, against a 52-week range of 45.5% to 126.9%. Its 20-day historical volatility was 71.3%.
Data as of November 17, 2026.